Chat

Alerts

Clinical Trials

Newsletters

oncology

neurology

business_development

2025-01-07 - 🧬 [nGram] Your Weekly Business Development Insights (31st Dec - 6th Jan): Amgen's Lung Cancer Treatment, Stryker's Acquisition, & FDA Approvals
2024-12-31 - 🧬 [nGram] Your Weekly Business Development Insights (24th Dec - 30th Dec): TEVIMBRA & RYBREVANT Approvals, Major Private Placements
2024-12-24 - 🧬 [nGram] Your Weekly Business Development Insights (17th Dec - 23rd Dec): FDA Approvals & Major Acquisitions
2024-12-17 - 🧬 [nGram] Your Weekly Business Development Insights (10th Dec - 16th Dec): FDA Approvals & Breakthroughs in Cancer & Diabetes
2024-12-03 - 🧬 [nGram] Your Weekly Business Development Insights (26th Nov - 2nd Dec): Novartis & PTC Deal, Senti Bio's CAR-NK Therapy, FDA Approvals
2024-11-26 - 🧬 [nGram] Your Weekly Business Development Insights (19th Nov - 25th Nov): FDA Approvals & Major Financing in Biopharma
2024-11-12 - 🧬 [nGram] Your Weekly Business Development Insights (5th Nov - 11th Nov): AbbVie's $9B Setback, FDA Approvals, & New Cancer Therapies
2024-11-06 - 🧬 [nGram] Your Weekly Business Development Insights (30th Oct - 5th Nov): Alzheimer's Trial Success, Roche's Liquid Biopsy, AbbVie Cancer Collaboration
2024-11-04 - 🧬 [nGram] Your Weekly Business Development Insights (28th Oct - 3rd Nov): AbbVie & EvolveImmune Cancer Collaboration, Eisai's Alzheimer's FDA Submission
2024-11-01 - 🧬 [nGram] Your Weekly Business Development Insights (25th Oct - 31st Oct): Zai Lab's KarXT Success & Biogen's Alzheimer's Collaboration
2024-10-25 - 🧬 [nGram] Your Weekly Business Development Insights (18th Oct - 24th Oct): BioNTech-OncoC4 Trial Hold, Novo & Ionis CHMP Nods, Novartis' Kisqali® Approval
2024-10-22 - 🧬 [nGram] Your Weekly Business Development Insights (15th Oct - 21st Oct): FDA Approvals & Key Clinical Trials
2024-10-18 - 🧬 [nGram] Your Weekly Business Development Insights (11th Oct 24 - 17th Oct 24): Merck's RSV Win, Pfizer's $1.5B Deal, FDA Approvals
2024-10-16 - 🧬 [nGram] Your Weekly Business Development Insights (9th Oct 24 - 15th Oct 24): Pfizer's $1.5B Cancer Deal & FDA Approvals

Charts